Temps Différé
London Stock Exchange - 17:35:22 26/01/2023
10644.00
GBX
-1.54%
Métier
Santé
Recherche pharmaceutique et médicale
Produits pharmaceutiques
Produits pharmaceutiques
Pharmacies - Autres
AstraZeneca PLC figure parmi les principaux groupes pharmaceutiques mondiaux. Le CA par source de revenus se répartit comme suit :
- ventes de produits (97,7%). Le CA par domaine thérapeutique se ventile entre oncologie (35,7%), maladies cardio-vasculaires, rénales et métaboliques (21,9%), maladies respiratoires et auto-immunes (16,5%) et autres (25,9% ; maladies inflammatoires, maladies neurologiques, maladies gastro-intestinales et maladies infectieuses) ;
- revenus de collaboration (2,3%).
La répartition géographique du CA est la suivante : Royaume Uni (8,7%), Europe continentale (20,9%), Amérique (37,5%) et Afrique-Asie-Australie (32,9%).
Nombre d'employés : 83 100 personnes.
Ventes par activité
2020
2021
Oncology
8 461.00
39.3%
9 487.36
34.5%
Cardiovascular, Renal & Metabolism
5 533.57
25.7%
5 831.44
21.2%
Respiratory & Immunology
4 177.47
19.4%
4 387.39
15.9%
COVID-19
-
-
2 909.90
10.6%
Rare Disease
-
-
2 232.23
8.1%
Other Medicines
2 017.38
9.4%
1 721.07
6.3%
Collaboration
566.93
2.6%
636.95
2.3%
GBP en Millions
Ventes par région
2020
2021
United States
6 983.25
32.5%
8 759.52
31.8%
China
4 168.11
19.4%
4 364.13
15.9%
Japan
2 001.79
9.3%
2 468.55
9%
United Kingdom
1 357.66
6.3%
2 359.48
8.6%
Other Asia, Africa and Australasia
1 196.24
5.6%
1 729.80
6.3%
Sweden
800.09
3.7%
1 688.35
6.1%
Other Rest of Europe
1 084.72
5%
1 417.14
5.2%
Germany
730.69
3.4%
1 080.49
3.9%
Other Americas
593.44
2.8%
874.72
3.2%
France
509.22
2.4%
665.31
2.4%
Canada
464.77
2.2%
561.33
2%
Spain
310.37
1.4%
420.27
1.5%
Italy
336.10
1.6%
419.54
1.5%
Australia
219.91
1%
397.73
1.4%
GBP en Millions
Dirigeants
Nom
Titre
Pascal Soriot
Chief Executive Officer & Executive Director
Aradhana Sarin
Chief Financial Officer & Executive Director
Leif Valdemar Johansson
Non-Executive Chairman
Menelas NICOLAS Pangalos
EVP-Biopharmaceuticals Research & Development
Pam P. Cheng
Executive VP-Operations & Information Technology
Henry D. Cremisi
Medical Director
Regina Fritsche Danielson
SVP, Head-Research & Early Development
Cindy L. Hoots
Chief Digital & Information Officer
Katarina Ageborg
Chief Compliance Officer & EVP-Sustainability
Marcus Wallenberg
Independent Non-Executive Director
Actionnaires
Nom
Actions
%
BlackRock Investment Management (UK) Ltd.
87 816 365
5,67%
Wellington Management Co. LLP
64 146 178
4,14%
The Vanguard Group, Inc.
53 576 000
3,46%
Investor AB (Investment Company)
51 587 810
3,33%
Capital Research & Management Co. (World Investors)
46 132 337
2,98%
Norges Bank Investment Management
33 949 000
2,19%
BlackRock Fund Advisors
29 534 960
1,91%
BlackRock Advisors (UK) Ltd.
21 258 411
1,37%
GQG Partners LLC
17 788 000
1,15%
BlackRock Advisors LLC
16 145 403
1,04%
Nom
Actions
%
Investor AB (Investment Company)
190 171 620
6,14%
T. Rowe Price Associates, Inc. (Investment Management)
75 385 016
2,43%
Wellington Management Co. LLP
52 246 916
1,69%
PRIMECAP Management Co.
45 614 110
1,47%
Capital Research & Management Co. (International Investors)
40 325 623
1,30%
Fidelity Management & Research Co. LLC
20 560 741
0,66%
GQG Partners LLC
18 377 731
0,59%
Capital Research & Management Co.
14 965 800
0,48%
Franklin Advisers, Inc.
14 499 844
0,47%
Regents of the University of California
10 965 024
0,35%
Nom
Actions
%
Caixa DTVM SA
283 703
0,0031%
Infinity Asset Management Administração de Recursos Ltda.